Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#101 of 458

Roger Song

Jefferies · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Aug 2025

Analyst rating accuracy & track record

Roger Song is an equity research analyst at Jefferies. Quantellect has scored 26 of their stock calls across 16 companies. Their picks beat their sector 43% of the time over the next 12 months, and their price targets were reached 33% of the time within a year.

Win % vs sector
43%
PT Hit % (12mo)
33%
Avg sector-excess
+2.0%
Scored calls
26
Tickers
16
Tier
Provisional

Track record

Quantellect has scored 26 of Roger Song's stock calls across 16 companies, dating back to 2021. Their rated stocks beat their own sector 43% of the time over the next 12 months. On a typical call, a Song pick returned +2.0% more than its sector over the following year.

Of the scored calls, 26 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
BMEABiomea Fusion Inc
Buy$5.00Aug 2025−37.4%Miss
BMEABiomea Fusion Inc
Buy$5.00Aug 2025−37.4%Miss
ATYRaTyr Pharma, Inc.
Buy$17.00Aug 2025−119.7%Miss
EQEquillium Inc
Buy$4.00Aug 2025+18.1%Miss
EQEquillium Inc
Buy$4.00Aug 2025+18.1%Miss
MBXMBX Biosciences, Inc. Common Stock
Buy$36.00Aug 2025+343.9%Hit
MBXMBX Biosciences, Inc. Common Stock
Buy$36.00Aug 2025+343.9%Hit
MBXMBX Biosciences, Inc. Common Stock
Buy$36.00Aug 2025+343.9%Hit
KNSAKiniksa Pharmaceuticals Ltd
Buy$54.00Jul 2025+143.7%Hit
REPLReplimune Group Inc
Buy$6.00Jul 2025+203.8%Hit
ALTAltimmune Inc
Buy$28.00Jun 2025−40.7%Miss
ALTAltimmune Inc
Buy$28.00Jun 2025−40.7%Miss
VXRTVaxart Inc
Buy$8.00Jun 2025−8.5%Miss
VXRTVaxart Inc
Buy$8.00Jun 2025−8.5%Miss
KNSAKiniksa Pharmaceuticals Ltd
Buy$45.00Apr 2025+93.0%Hit
AKBAAkebia Ther
Buy$6.00Apr 2025−31.1%Miss
SANASana Biotechnology Inc
Buy$7.00Mar 2025+13.4%Miss
ACRSAclaris Therapeutics Inc
Buy$7.00Nov 2024−46.4%Miss
BIOABioAge Labs, Inc
Buy$42.00Oct 2024−75.4%Miss
NVAXNovavax Inc
Buy$25.00Oct 2024−13.1%Miss
ZBIOZenas BioPharma, Inc. Common Stock
Buy$35.00Oct 2024+55.5%Miss
NVAXNovavax Inc
Buy$31.00Oct 2024−30.0%Miss
KNSAKiniksa Pharmaceuticals Ltd
Buy$40.00Sep 2024+56.7%Miss
ATYRaTyr Pharma, Inc.
Buy$9.00Sep 2024+207.3%Miss
PCVXVaxcyte Inc
Buy$129.00Sep 2024−59.5%Miss
CRVSCorvus Pharmaceuticals Inc
Buy$8.00Dec 2021−79.4%Miss
Prev1
Go to

Roger Song: analyst track record FAQ

Is Roger Song a good stock analyst?

Yes, by track record. Roger Song ranks number 101 of 458 of the analysts Quantellect scores, with a Q Score of 56 out of 100. Past results do not guarantee future ones.

What is Roger Song's win rate?

Roger Song's win rate is 43%. Across 26 scored calls, their rated stocks beat their sector 43% of the time over the next 12 months. On a typical call they returned +2.0% more than the sector.

What stocks and sectors does Roger Song cover?

Roger Song covers 16 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Roger Song's price targets accurate?

Roger Song's price targets are reached within 12 months 33% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Roger Song's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Roger Song rank among Wall Street analysts?

Roger Song ranks number 101 of 458 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.